Ignite Creation Date:
2025-12-24 @ 8:00 PM
Ignite Modification Date:
2025-12-29 @ 1:48 PM
Study NCT ID:
NCT04485104
Status:
TERMINATED
Last Update Posted:
2025-10-31
First Post:
2020-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
Sponsor:
Jazz Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-19
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-21
First Submit QC Date:
None
Study First Post Date:
2020-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-18
Results First Submit QC Date:
None
Results First Post Date:
2025-10-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-17
Last Update Post Date:
2025-10-31
Last Update Post Date Type:
ESTIMATED